Introduction
Oncogenes transform cells by virtue of their unregulated and activated tyrosine kinase. Substrate phosphorylation and autophosphorylation leads to constitutive association of the activated tyrosine kinase with intracellular signaling molecules. This association appears to be mediated by interactions of autophosphorylated tyrosine residues with SH2-containing signaling molecules which either exhibit catalytic activity on their own or serve as adapter molecules for proteins with catalytic activity capable of initiating signaling cascades that lead to proliferation and transformation of the cell (Pawson, 1995) . Chronic myelogenous leukemia (CML) and a subset of acute lymphoblastic leukemia (ALL) are clonal proliferative disorders associated with the t(9;22) translocation whereby the breakpoint cluster region (bcr) on chromosome 22 juxtaposes to the c-Abl gene on chromosome 9. The chimeric gene generates a fusion protein containing the ®rst 927 or 902 aminoacids (aa) of Bcr in CML, while in ALL only the ®rst 426 aa of Bcr are fused to c-Abl (Chan et al., 1987; de Klein et al., 1982; Kurzrock et al., 1987) . Both Bcr-Abl fusion proteins exhibit an increased tyrosine kinase activity and their oncogenic potential has been demonstrated using in vitro cell culture systems as well as in in vivo mouse models (Daley and Baltimore, 1988; Gishizky and White, 1992; Lugo et al., 1990; Lugo and Witte, 1989; McLaughlin et al., 1987; Young and Witte, 1988) .
SH2-containing molecules known to interact with Bcr-Abl include the adapter molecule Grb2 and SHC (Pendergast et al., 1993b; Puil et al., 1994; Tauchi et al., 1994a) , the phosphotyrosine phosphatase Syp (Tauchi et al., 1994b) and the regulatory subunit (p85) of phosphatidylinositol 3'-kinase (p85PI3K) (Skorski et al., 1995) .
It has been shown recently, that the association of Bcr-Abl with the Ras adapter molecule Grb2 correlates with activation of the Ras pathway in Bcr-Abl transformed ®broblasts (Pendergast et al. 1993b; Puil et al., 1994; Tauchi et al., 1994a) . Mutation of the Grb2 binding site in Bcr-Abl at position tyrosine 177 (Y177) to phenylanaline (F177) is associated with reduction of the transforming activity of Bcr-Abl in ®broblasts (Pendergast et al., 1993b; Puil et al., 1994) . Furthermore, expression of a dominant-negative Grb2 in CML cells could reverse the transformed phenotype . It has, therefore, been hypothesized that Bcr-Abl through binding to the Ras adapter molecule, Grb2, leads to constitutive Ras activation and, thereby, transformation of the cell. However, the signi®cance of this Bcr-Abl/Grb2 interaction for the transforming activity of Bcr-Abl is unclear as Bcr-Abl mutants which lack the Grb2 binding site can still activate Ras leading to a mitogenic signal in some cellular systems Goga et al., 1995) . Therefore, it was speculated that redundant signaling pathways must exist for Bcr-Abl to induce a mitogenic signal. It is clear in all biological model systems tested so far that the potential of Bcr-Abl to transform cells requires an upregulated and active tyrosine kinase indicating that autophosphorylation and/or substrate phosphorylation is indispensable for Bcr-Abl transformation. Since Grb2 binding to Bcr-Abl at Tyr(P)177 seems to be insucient for transformation of hematopoietic cells, we have attempted to isolate additional SH2-containing proteins binding to Bcr-Abl at dierent autophosphorylation sites which may contribute to the mitogenic signal initiated by Bcr-Abl. To screen for phosphotyrosine-dependent protein ± protein interactions, we performed a modi®ed yeast two-hybrid screen with Bcr-Abl. Autophosphorylation of Bcr-Abl in this modi®ed yeast system was accomplished by using the DNA-binding protein LexA that leads to dimerization and crossphosphorylation of the fused bait (O'Neill et al., 1994; Weidner et al., 1996) . In this article, we describe the identi®cation of Grb10, a novel SH2-containing protein, which interacts with Bcr-Abl in yeast, in vitro and in vivo. Grb10 was recently cloned by screening of an expression library with the tyrosinephosphorylated carboxy-terminus of the epidermal growth factor receptor (EGFR) (Ooi et al., 1995) . Three distinct splice variants of Grb10 have been described (mGrb10, hGrb-IR, hGrbsvIR) (Liu and Roth, 1995; O'Neill et al., 1996; Frantz et al., 1997) . Grb10 belongs to an emerging family of SH2-containing signaling molecules including Grb7 and Grb14. These family members share a SH2 domain, a pleckstrin domain and a proline-rich region (Ooi et al., 1995; Daly et al., 1996) . The precise function for these SH2-containing adapter molecules has not been fully elucidated. However, the existence of highly conserved regions known to be of potential importance for protein ± protein interactions suggests a role for these adapter proteins in growth regulation. Despite its cloning in conjunction with the EGF receptor, Grb10 could not be shown to bind to the EGF receptor in vivo (Ooi et al., 1995) . In contrast, recently an in vivo association of Grb10 with the Ret receptor, the Insulin receptor and the ELK receptor was demonstrated suggesting that Grb10 may play a role in the biology of these receptors (Hansen et al., 1996; Pandey et al., 1995; Stein et al., 1996; Frantz et al., 1997; O'Neill et al., 1996) .
Binding of Grb10 to Bcr-Abl is kinase-dependent and occurs between the Grb10 SH2 domain and a BcrAbl autophosphorylation site that is dierent from Tyr(P)177. This interaction was con®rmed in vitro, in vivo, i.e. in lymphoid cells overexpressing Bcr-Abl as well as in CML cells obtained from a patient in CML blast crisis (K562). No tyrosine phosphorylation of Grb10 was observed after complex formation with BcrAbl in various cells investigated. McWhirter et al. (1993) showed that a mutant lacking the Grb10 autophosphorylation site had a reduced capacity to transform Rat-1 ®broblasts. In line, herewith, the Grb10-Bcr-Abl complex also seems to be important for Bcr/Abl-induced interleukin-3 (IL-3) independent growth of Ba/F3 cells. These data indicate that the adapter molecule Grb10 plays a role in the Bcr-Abl mediated oncogenicity.
Results
Bcr-Abl binds to Grb10 in the yeast two-hybrid system A yeast two-hybrid screen was performed to identify proteins which interact with Bcr-Abl in a phosphotyrosine-dependent manner. To achieve autophosphorylation of the bait in yeast, Bcr-Abl was fused to LexA, a DNA binding protein which leads to dimerization and subsequent phosphorylation of the fused bait (Weidner et al., 1996) . Interaction of two proteins in this system allows for growth on histidine-free medium and for expression of b-galactosidase. A mouse embryo c-DNA library was screened with Bcr-AblDSal fused to LexA (the actin-binding domain in Bcr-Abl was deleted to avoid the isolation of actin coding clones). Expression and phosphorylation of the transfected Bcr-Abl constructs in yeast was veri®ed by Western blotting analysis (data not shown) and the clone displaying the highest autokinase activity was subsequently used. 3610 7 colonies were screened and 62 clones were isolated which speci®cally interacted with Bcr-Abl in the yeast system. Among these clones were proteins already known to bind to Bcr-Abl both in a phosphotyrosine-dependent and -independent manner like the SH2 domains of Grb2 and p85PI3K, and the SH3 domain of Crk, respectively (Pendergast et al., 1993b; Puil et al., 1994; Ren et al., 1994) . Ten of the clones obtained coded for the novel SH2-containing adapter molecule Grb10 (Ooi et al., 1995) . Six out of these ten clones represented individual Grb10 sequences as shown in Figure 1 . All the Grb10 clones isolated included the SH2 domain of Grb10 (Figure 1 ) suggesting that the interaction takes place between the SH2 domain of Grb10 and a Tyr(P) autophosphorylation site in Bcr-Abl. Interaction of Bcr-Abl and Grb10 in yeast was speci®c since none of the Grb10 clones interacted with a nonspeci®c control protein (lamin, data not shown). In an independent yeast screen utilizing a cDNA library obtained from a CML cell line (K562), we again identi®ed the SH2 domain of a human splice variant of Grb10 (hGrb10svIR) (data not shown). Thus, in two independent yeast two-hybrid screens, one of which using a human CML cell line cDNA library, Grb10 was identi®ed as a binding partner of Bcr-Abl. To determine whether this interaction was autophosphorylation-dependent, a kinase-defective Bcr-Abl (Bcr-AblKD) was assessed for its interaction with the Grb10 SH2 domain (clone B17) along with the Grb2-SH2 domain as negative and the Crk-SH3 domain as positive control (Figure 2a) . While the wt-Bcr-Abl bound to all three constructs, the Grb10 interacts with Bcr-Abl R Yuan Bai et al kinase defective Bcr-Abl failed to induce histidine autotrophy in yeast with the Grb2-SH2 and the Grb10-SH2 domains demonstrating the phosphotyrosine-dependency of these interactions. The interaction of Grb10 with Bcr-Abl in yeast was comparable in strength both by histidine autotrophy (Figure 2a ) and b-galactosidase activity (data not shown). As expected, the Crk-SH3 domain which is known to bind to a proline rich sequence in the Abl C-terminus (Feller et al., 1994a; Ren et al., 1994) , still showed interaction with the kinase-defective Bcr-Abl in yeast ( Figure 2a ). Thus, binding of Grb10 to Bcr-Abl is mediated by an interaction between the Grb10-SH2 domain and a BcrAbl autophosphorylation site.
To de®ne the region of interaction more closely, the mutants listed in Figure 2b and c were expressed in yeast and examined for their interaction with the Grb10-SH2 domain. Bcr alone (Bcr aa1-509), as well as Abl alone (Abl aa1-1097), failed to interact with Grb10 suggesting that the interaction took place at a phosphorylation site in Bcr within Bcr-Abl ( Figure  2b ). As expected the Grb2-SH2 domain also failed to interact with Abl or Bcr alone while the Crk-SH3 domain bound to the Abl construct. Figure 2c shows the interaction of Bcr1-242/Abl which carries a deletion of Bcr aa243-509 but still possesses the known autophosphorylation site Tyr(P)177. Therefore, this construct retains the ability to bind to the Grb2-SH2 and the Crk-SH3 domains but is not capable of binding to the Grb10-SH2 domain ( Figure 2c ). Thus, the autophosphorylation site for the Grb10-SH2 domain diers from that for the Grb2-SH2 domain (Tyr(P)177) and is located between Bcr aa243-509.
Bcr-Abl speci®cally interacts with the Grb10 SH2 domain in vitro
To con®rm the yeast binding results in vitro, an in vitro binding assay was performed. Bcr-Abl mutants were in vitro-translated and autophosphorylated and assessed for their ability to bind to a bacterially puri®ed GST-GRB10-SH2 fusion protein. As expected, the Bcr-Abl mutants harboring Bcr sequences aa243-509 bound to the Grb10 SH2 domain (Figure 3a , middle panel, lanes 1, 3 and 9), whereas the Bcr-Abl mutants carrying a deletion of this region (Bcr1-242/Abl, Bcr1-175/Abl), failed to bind to the Grb10-SH2 domain ( Figure 3a , middle panel, lanes 5 and 7). The Bcr1-446/Abl mutant bound Grb10 and therefore the interaction region could be further delineated to Bcr aa243-446. Consistent with the fact that the Grb2 binding site is at Tyr177, the Grb2-SH2 domain bound to Bcr/1-509-Abl, Bcr/1-446-Abl and Bcr/1-242-Abl but not to Bcr/1-175-Abl or Bcr/ 177FAbl ( Figure 3a , upper panel, lanes 1, 3, 5, 7 and 9). All binding reactions were speci®c in as much as GST alone did not bind to any Bcr-Abl construct ( Figure 3a , lower panel). Furthermore, the Grb10-Bcr-Abl interactions appeared to be at least as strong as the Grb2-BcrAbl interaction in vitro corroborating the results obtained in yeast (Figure 3a , compare the bound and ow-through fractions of the upper panel and the middle panel, lanes 1 ± 4). The Bcr region 243 ± 446 contains seven potential autophosphorylation sites. In an attempt to identify the exact tyrosine residue responsible for binding to the Grb10-SH2 domain phosphopeptide competition experiments with ten amino acid peptides encompassing the seven autophosphorylation sites were performed. However, none of the peptides even at high concentration (400 mM) was able to block the binding of the Grb10-SH2 domain to Bcr-Abl (data not shown). We also constructed a series of tyrosine to phenylalanine Bcr-Abl mutants including Bcr-Abl231F, Bcr-Abl246F, Bcr-Abl276F, BcrAbl283F, Bcr-Abl316F, Bcr-Abl328F, Bcr-Abl360F and Bcr-Abl436F. None of these mutants lost the ability to bind to the Grb10-SH2 domain in vitro (Figure 3b and data not shown). The inability to exactly determine a single Bcr-Abl autophosphorylation site responsible for Grb10 binding was also reported by several other investigators (Frantz et al., 1997; O'Neill et al., 1996) . Therefore, the binding site of the Grb10-SH2 domain seems to be more complex and might involve several autophosphorylation sites or additional sequences in the Brc region aa243-446.
Absorption of endogenous Bcr-Abl from CML cells to Grb10
Binding of Grb10 to Bcr-Abl requires autophosphorylation of a new autophosphorylation site in vitro and in yeast. To test whether this binding also occur in vivo, we examined Bcr-Abl-Grb10 complex formation in CML cells (K562).
Binding of full length Bcr-Abl (210kd Bcr-Abl) could be demonstrated with the GST Grb10-SH2 domain selecting Bcr-Abl from these cell lysates ( Figure 4a , left panel), while an unrelated SH2 domain (Nck-SH2) or a control protein (GST) showed no binding ( Figure 4a , left panel).
Grb10/Bcr-Abl complex formation in CML cells in vivo
To determine whether a Bcr-Abl/Grb10 complex existed in vivo in leukemic cells co-immunoprecipitation experiments were performed with CML cells obtained from a patient in blast crisis (K562). As shown in Figure  4b , the Grb10 antibody is able to precipitate Bcr-Abl from these CML cells. No endogenous c-Abl was detectable in the Grb10 co-immunoprecipitation analysis (Figure 4b, left panel) . In line herewith, the Grb10 antibody failed to precipitate any endogenous c-Abl in a Bcr-Abl negative leukemic cell line (HL-60) (Figure 4b S-methionine-labeled. 50 ml of the translation mix was ®rst allowed to autophosphorylate in vitro and then incubated with 5 mg puri®ed GST-Grb10-SH2 and GST-Nck-SH2 (Con.) as control. The bound fractions were separated by SDS ± PAGE and the Bcr-Abl mutants visualized by autoradiography 
Association of Grb10 and Bcr-Abl is kinase activation dependent in vivo
To examine whether the complex formation of Bcr-Abl with Grb10 is dependent on an activated kinase, a temperature-sensitive mutant of Bcr-Abl (tsBcr-Abl) was introduced into the IL-3 dependent hematopoietic cell line Ba/F3. Following antibiotic selection and single cell cloning by limited dilution, one clone was further characterized for its tsBcr-Abl expression and kinase activity by Western blotting. Cell lysates from tsBcr-Abl transfected Ba/F3 cells were kept at the restrictive or permissive temperature for 3 h and cell lysates were analysed with an Abl-speci®c and a Tyr(P)-speci®c antibody. These cells express tsBcr-Abl at the permissive (328C) and restrictive (398C) temperature at comparable levels ( Figure 5a , left panel). Three hours after a temperature shift to 328C the cells contained enhanced levels of tyrosinephosphorylated tsBcr-Abl demonstrating activation of tsBcr-Abl at the permissive temperature ( Figure 5a , right panel). To investigate whether this kinase activation leads to enhanced Grb10 binding, lysates of cells grown at restrictive or permissive temperatures were incubated with a GST-Grb10-SH2 fusion protein.
As shown in Figure 5b , left panel, a little Bcr-Abl protein could be pulled down from cells kept at the restrictive temperature probably re¯ecting leaky kinase activity even in cells grown at 398C (see Figure 5a , right panel). However, at the permissive temperature increased amounts of tsBcr-Abl bound to the Grb10-SH2 domain demonstrating that complex formation is kinase-dependent. Under the same conditions tsBcrAbl could not be precipitated with GST beads alone neither at the restrictive nor at the permissive temperatures ( Figure 5b , left panel). Kinase-dependency of the Bcr-Abl/Grb10 complex could also be demonstrated in vivo by co-immunoprecipitation analysis. As shown in Figure 5b , right panel, the Grb10 antibody failed to precipitate Bcr-Abl protein at the restrictive temperature when the kinase was inactive. However, after shifting to the permissive temperature, tsBcr-Abl could be immunoprecipitated by the Grb10 antibody. Thus, complex formation of Brc-Abl and Grb10 is kinase-dependent in vitro and in vivo.
Analysis of the transforming abilities of Bcr-Abl mutants
We used Ba/F3 cells as a model system to analyse the transforming abilities of Bcr-Abl mutants. Ba/F3 cells have been shown to gain growth factor independence upon transfection of Bcr-Abl (Daley and Baltimore, 1988) . This transforming capability of Bcr-Abl has been shown to require an active tyrosine kinase and an oligomerization signal within the ®rst 63 AA of Bcr (Daley and Baltimore, 1988; McWhirter et al., 1993) . Other functional domains which have been shown to be essential for transformation of ®broblasts, however, are dispensable for abrogation of IL3-dependent growth of Ba/F3 cells, e.g. the Grb2 binding site and the SH2 domain Goga et al., 1995; McWhirter and Wang, 1993) . The biological function of Grb10 is so far unknown. However, since Grb10 lacks a catalytic domain and consists of domains known to be involved in protein complex formation, it was hypothesized, like Grb2, the Grb10 molecule could also be an adapter molecule linking Bcr-Abl to downstream signaling targets (Ooi et al., 1995) . To test whether presumed downstream targets are important for IL-3-independent growth of Ba/F3 cells, the Bcr/1-509-Abl as well as the Bcr/1-242-Abl mutant which lacks the ability to interact with GRB10 and a kinase-defective Bcr-Abl mutant as control, were transfected into Ba/F3 cells. After antibiotic selection of the transfected clones, protein expression was veri®ed by Western blotting analysis (data not shown). Cells were then kept in medium lacking IL-3 and the growth of cells was monitored over a period of 5 weeks to determine the progression to IL-3 independence. As shown in Figure 6 both Bcr/1-509-Abl and Bcr/1-242Abl could render Ba/F3 cells IL-3-independent. However, the Bcr/1-242 mutant had a weaker transforming potential and cells transfected with this construct had signi®cantly delayed onset of IL-3-indpendent growth demonstrated in two independent experiments. Since the Bcr/1-242-Abl mutant can not form a complex with Grb10, these experiments indicate that this interaction is important but not absolutely required for induction of growth factor independence in these cells. Additionally, McWhirter et al. have shown by using the same Bcr/1-242-Abl mutant that the ability of this mutant to induce focus formation in Rat-1 ®broblasts is impaired (McWhirter et al., 1993) . Taken together, the data indicate that like other important functional domains of Bcr-Abl (SH2, Tyr(P)177), the Grb10 binding site is important but not sucient for the transforming activity of Bcr-Abl which redundantly activates the mitogenic pathway by utilizing several autophosphorylation sites. 
Discussion
Bcr-Abl is an oncogenic tyrosine kinase capable of transforming myeloid cells and certain ®broblasts (Daley and Baltimore, 1988; Lugo et al., 1990; Lugo and Witte, 1989) . A large body of evidence indicates that the activated and upregulated tyrosine kinase of Bcr-Abl is responsible for its transformation potential. Mutational analysis have shown that autophosphorylation of Bcr-Abl is important for its transforming properties (Pendergast et al., 1993a,b; Puil et al., 1994) . One autophosphorylation site of Bcr-Abl (Tyr(P)177) could be identi®ed and was subsequently shown to interact with the Ras adapter Grb2 thereby possibly linking Bcr-Abl to the mitogenic Ras pathway (Pendergast et al., 1993b; Puil et al., 1994) . It could be demonstrated that this autophosphorylation site was necessary to transform Rat-1 ®broblasts. However, this site appeared to be dispensable for the transformation of myeloid cells or induction of tumors in nude mice suggesting the presence of additional autophosphorylation sites binding to additional adapter molecules which contribute to the redundant transforming potential of Bcr-Abl Goga et al., 1995) . To address this possibility, we have performed a yeast two-hybrid screen which allows interchain phosphorylation of Bcr-Abl on tyrosine residues in yeast. By screening a mouse embryo library and a K562 library, we have identi®ed a series of signaling molecules already known to bind to Bcr-Abl in a phosphotyrosine-dependent and -independent manner. Among them were the SH2 domains of Grb2, PI3kinase and the SH3 domain of Crk. These signaling molecules have been previously identi®ed to interact with Bcr-Abl and to be of importance for the biological function of Bcr-Abl (Feller et al., 1994b; Pendergast et al., 1993b; Puil et al., 1994; Ren et al., 1994) . This demonstrates that autophosphorylation of Bcr-Abl in yeast resembles the autophosphorylation of tyrosine residues occurring in vivo. Therefore, this is a useful system to screen for Tyr(P)-dependent binding partners of Bcr-Abl. Among the clones identi®ed was a new SH2-containing adapter molecule, Grb10, which was independently isolated six times from a mouse embryo library. In addition, a human splice variant of Grb10 (hGrb10svIR) (Liu et al., 1995; O'Neill et al., 1996) could be isolated in the yeast two-hybrid screen with a library obtained from a CML cell line (K562). Grb10 belongs to an emerging family of SH2-containing adapter molecules including Grb7 and the recently identi®ed Grb14 (Ooi et al., 1995) . These adapter molecules share a general feature in that they consist of a N-terminal proline rich region, a central pleckstrin domain and a C-terminal SH2 domain (Ooi et al., 1995) . The exact function of pleckstrin domains has not been fully elucidated as yet. Studies in C. elegans which contain a homologous region, called F10E9.6, indicate a function in cell migration (Wilson et al., 1994) . In addition, pleckstrin domains were found in a variety of proteins known to exert important functions in signal transduction (Lemmon et al., 1996) . It has been proposed that pleckstrin domains are involved in speci®c protein ± protein interactions. The general structure of highly conserved domains reveals that Grb10 functions as an adapter molecule for signal transduction control. It was speculated that Grb10 couples activated receptor tyrosine kinases via its SH2 domain to more downstream signaling which may bind to the proline-rich region or to the pleckstrin domain of Grb10. Hereby, Grb10 is perhaps able to deliver a pro-mitogenic signal. Experiments with a putative dominant-negative mutant of Grb10 (the isolated SH2 domain) expressed in ®broblasts show inhibition of DNA synthesis (O'Neill et al., 1996) . Furthermore, overexpression of Grb7 in certain types of breast cancer and Grb14 in estrogen receptor-positive breast cancer cells and prostate cancer suggest a role for this adapter family in oncogenesis (Stein et al., 1994; Daly et al., 1996) .
Sequence analysis of the six independent Grb10 clones isolated by two-hybrid screening indicated that the interaction with Brc-Abl indeed required the SH2 domain of Grb10. Interaction involved novel Bcr-Abl autophosphorylation sites dierent from Tyr(P)177 located between Bcr aa242-446. We were not able to identify a single tyrosine residue responsible for Grb10-SH2 binding to Bcr-Abl. Previous studies have also failed to detect a single Grb10-SH2 binding site for the insulin receptor (O'Neill et al., 1996; Frantz et al., 1997) . Therefore, it is reasonable to speculate that the Grb10-SH2 domain requires more than a single phosphorylated tyrosine for interaction with Bcr-Abl. Complex formation of Grb10 with Bcr-Abl was demonstrated in vivo by co-immunoprecipitation of the endogenous proteins in CML cells. Quantitative analysis revealed that about 5% of the endogenous Bcr-Abl in these cells is complexed to Grb10. Furthermore, we showed that an upregulated tsBcrAbl tyrosine kinase is necessary for this interaction. Recently, a paper described in vitro binding of the Abl-SH3 domain to a proline rich stretch in Grb10 (Frantz et al., 1997) . None of our Grb10 clones isolated in yeast contained this proline rich region. In addition our data with the tsBcr-Abl expressing Ba/F3 cells demonstrated Grb10 complex formation with Bcr-Abl to be strictly kinase dependent. Thus, the SH2 domain of Grb10 rather than the proline rich region seems to control complex formation with Interestingly, a Bcr-Abl mutant which lost the ability to interact with Grb10 could still render Ba/F3 cells IL-3-independent however, with a signi®cantly lower eciency. In dierent biological assay systems, dierent Bcr-Abl domains are required for transformation. For example, it was shown that the Abl SH2 domain is required for ®broblasts transformation by Bcr-Abl, but not for Ba/F3 growth factor-independence (McWhirter et al., 1993) . Similarly, the Tyr(P)177 is required to transform ®broblasts, but not to render Ba/F3 cells IL-3-independent (Pendergast et al., 1993b) . It was shown that in hematopoetic cells, combinations of mutations are required to abolish the transforming activities of Bcr-Abl and that these functional domains act in concert to render Ba/F3 cell growth factor-independent Goga et al., 1995) . In this light, our ®ndings showing that mutation of the Grb10 interacting domain alone in Bcr-Abl does not completely diminish Bcr-Abl transforming activity in the Ba/F3 assay was not surprising. In line herewith, data of McWhirter et al. suggest that the Grb10-Bcr-Abl complex also seems to be important to transform ®broblasts. It appears reasonable to assume that BcrAbl activates dierent signaling pathways, e.g. activation of Ras and STATS, modulation of the cytoskeleton, inhibition of apoptosis or induction of cytokine release (Anderson and Mladenovic, 1996; Bedi et al., 1995; Carlesso et al., 1996; Cortez et al., 1995; Gotoh et al., 1995; Sawyers et al., 1995) . For the development of leukemia, a combination of these Bcr-Abl functions seems to be required. It will be necessary to study the biological function of Grb10 in greater detail to de®ne its role in the pathogenesis of CML. The fact that Grb10 binding to Bcr-Abl is strong (at least as strong as that of Grb2) and that it can be easily co-immunoprecipitated from endogenous proteins in CML cells, along with the observation that the Bcr-Abl/Grb10 complex is important for the transformation of both ®broblasts and hematopoietic cells, strongly support the hypothesis that Grb10 plays an important, though yet unidenti®ed role, in the development of CML. Association of the Grb10 adapter family with certain types of malignancies (O'Neill et al., 1996) as well as experimental data supporting a role of Grb10 in mitogenesis encourage this hypothesis.
Materials and methods

Cell culture and transfections
IL-3-dependent Ba/F3 cells were cultured in RPMI 1640 supplemented with 10% FCS and 2 ng/ml murine IL-3. K562 and HL-60 were cultured in RPMI 1640 supplemented with 10% FCS. Expression plasmids used in this study have been previously described (McWhirter et al., 1993; Wang, 1991, 1993; Renshaw et al., 1995) . Tyrosine to phenylalanine mutants Bcr/231F-Abl, Bcr/246F-Abl, Bcr/ 276F-Abl, Bcr/283F-Abl, Bcr/316F-Abl, Bcr/328F-Abl, Bcr/ 360F-Abl and Bcr/436F-Abl were made by site directed mutagenesis using overlapping oligonucleotides and Pfu DNA polymerase (Stratagene, Heidelberg, Germany). Bcr/ 177F-Abl was kindly provided by O Witte, Los Angeles, USA. The Bcr-Abl temperature sensitive mutant (tsBcr-Abl) was generated by subcloning a temperature sensitive v-Abl mutant (DP) (Kipreos et al., 1987) into pSLXBcr-Abl (McWhirter et al., 1993) . Ba/F3 subclones expressing tsBcrAbl, Bcr-Abl, Bcr-Abl/KD (kinase defective) and Bcr/1-242-Abl were generated by transfection of the corresponding pSLXCMV vector into Ba/F3 cells by electroporation as previously described (McWhirter and Wang, 1993 ) using a gene pulser (IBI geneZapper 450/2500, Eastman Kodak, New Haven, USA) and selecting for G418-resistant clones. Transfected cells were resuspended at 0.5610 6 cells per ml in medium lacking a source of IL-3. The number of viable cells in each culture was determined at various time points using trypan blue staining and a hemocytometer.
Yeast two-hybrid system
The cDNA for Bcr-AblDSal (the actin-binding domain of Bcr-Abl was deleted to avoid detection of actin coding clones) was fused to LexA sequences in the yeast expression vector BTM116 (Weidner et al., 1996) . Dierent hybrid cDNAs with dierent spacing between the LexA and Bcr-Abl coding sequences were transfected into the yeast strain L40 (which contains a His3 and LacZ reporter gene) and assayed for Bcr-Abl tyrosine kinase autophosphorylation activity. The yeast clone displaying the highest autokinase activity was subsequently used and assayed for interaction with proteins encoded by a VP16 activation domain cDNA library from E10.5 mouse embryos . Alternatively, a cDNA library prepared from K562 cells was used (purchased from Clontech, Heidelberg, Germany). Mutants of Bcr-AblDSal including Bcr-AblDSalKD, Bcr (Bcr aa1-509), AblDSal (Abl aa1-934) and Bcr1-242/AblDSal were subcloned into the BTM-Bcr-AblDSal Vector used for the yeast twohybrid screen.
GST-Fusion proteins and pull down assay
The Grb10 SH2 domain (aa519-621), the Grb2 SH2 domain (aa54-164) and the Nck SH2 domain (aa270-377) were cloned in frame into the vector pGex2TK to make GST (glutathione S-transferase)-fusion proteins (Smith and Johnson, 1988) . Wt-and mutant-Bcr-Abl proteins were in vitro-translated and 35 S-radiolabeled using the TNT system (Promega). The translation mix was diluted to a ®nal concentration of 25 mM Tris⋅HCl (pH 7.4), 10 mM MgCl 2 , 1 mM dithiothreitol and 100 mM cold ATP and incubated for 30 min at 48C to allow for autophosphorylation of the translated proteins. Reactions were stopped by dilution to a ®nal concentration of 10 mM Tris⋅HCl (pH 7.4), 5 mM EDTA, 130 mM NaCl, 1% Triton, 1 mM phenylmethylsulfonyl¯uoride and 10 mg/ml of each phenantroline, aprotinin, leupeptin and pepstatin (lysis buer). 5 mg of GST-fusion proteins were added and incubated for 1 h at 48C. Protein complexes were collected on glutathioneagarose beads (Pharmacia, Freiburg, FRG), washed thoroughly with lysis buer and subjected to SDS ± PAGE. In vitro translated proteins were visualized by autoradiography.
For binding experiments with cell extracts, 1610 7 cells were solubilized in lysis buer, precleared with glutathionebeads and incubated with 5 mg of GST-fusion proteins for 1 h at 48C. Protein complexes were collected on glutathionebeads and subjected to SDS ± PAGE. Bcr-Abl and Abl was detected by immunoblotting using an Abl-speci®c antibody 8E9 (Duyster et al., 1995) .
Grb10 interacts with Bcr-Abl
Immunoprecipitation and immunoblotting
Immunoprecipitation was done as previously described (Duyster et al., 1995; McWhirter and Wang, 1991) . Brie¯y, 1610 7 cells were solubilized in lysis buer containing 10 mM Tris⋅HCl (pH 7.4), 5 mM EDTA, 130 mM NaCl, 1% Triton, 1 mM phenylmethylsulfonyl¯uoride, 1 mM Na 3 VO 4 and 10 mg/ml of each phenantroline, aprotinin, leupeptin and pepstatin. After clari®cation by centrifugation, Grb10 was precipitated with anti-Grb10 antibody (Santa Cruz, USA), and Bcr-Abl and Abl were precipitated with antiAbl antibody 8E9. Immunoprecipitations were analysed by SDS ± PAGE followed by immunoblotting with anti-Abl (8E9) and monoclonal antiphosphotyrosine antibody (PY20) as previously described (Duyster et al., 1995; McWhirter and Wang, 1991) .
